Childhood asthma: exhaled nitric oxide in relation to clinical symptoms

Bronchial asthma is associated with increased levels of exhaled nitric oxide which are suppressible by glucocorticosteroid inhalation. Children with bronchial asthma were studied to elucidate the relation between endogenous NO release and recent symptoms of bronchial obstruction. Twenty-five children with atopic asthma and 11 healthy control subjects were enrolled and exhaled NO was studied using chemiluminescence analysis. The subjects breathed purified air (<0.5 parts per billion (ppb) NO) exclusively through their mouths. Orally expired NO was measured during continuous nasal aspiration (1.3 L x min(-1)) to remove nasally produced NO. Nasal NO concentration was determined within the aspirated gas. Orally expired NO concentration was 2.5+/-0.3 ppb (mean +/-SEM) in healthy control subjects, 3.19+/-0.88 ppb (NS) in symptom-free children, and 8.28+/-0.81 ppb (p< or =0.01) in children with bronchial asthma who had had recent symptoms of bronchial obstruction. Similarly, in the subgroup of children treated regularly with inhaled glucocorticosteroids those with recent symptoms had significantly higher orally exhaled NO concentrations than healthy control subjects (9.5+/-1.5 ppb, p<0.05). The nasal NO concentration was 152.8+/-12.7 ppb in healthy control subjects and not significantly different in asthmatic children. In this group of asthmatic children, recent symptoms of bronchial obstruction were linked to significantly higher concentrations of NO in orally exhaled gas and to increased oral NO excretion rates. If substantiated by further studies, measurement of orally exhaled NO during nasal aspiration may become useful to monitor disease control in asthmatic children.

This article has been cited by other articles:

				A. Zacharasiewicz, N. Wilson, C. Lex, E. M. Erin, A. M. Li, T. Hansel, M. Khan, and A. Bush Clinical Use of Noninvasive Measurements of Airway Inflammation in Steroid Reduction in Children Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1077 - 1082. [Abstract] [Full Text] [PDF]

				P.J. Franklin, S.W. Turner, R.C. Mutch, and S.M. Stick Comparison of single-breath and tidal breathing exhaled nitric oxide levels in infants Eur. Respir. J., March 1, 2004; 23(3): 369 - 372. [Abstract] [Full Text] [PDF]

				Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al. Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Eur. Respir. J., July 1, 2002; 20(1): 223 - 237. [Abstract] [Full Text] [PDF]

				W. Formanek, D. Inci, R.P. Lauener, J.H. Wildhaber, U. Frey, and G.L. Hall Elevated nitrite in breath condensates of children with respiratory disease Eur. Respir. J., March 1, 2002; 19(3): 487 - 491. [Abstract] [Full Text] [PDF]

				G. L. Hall, B. Reinmann, J. H. Wildhaber, and U. Frey Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure J Appl Physiol, January 1, 2002; 92(1): 59 - 66. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				E. BARALDI, M. SCOLLO, C. ZARAMELLA, S. ZANCONATO, and F. ZACCHELLO A Simple Flow-Driven Method for Online Measurement of Exhaled NO Starting at the Age of 4 to 5 Years Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1828 - 1832. [Abstract] [Full Text]